Joensuu H, Kellokumpu-Lehtinen P-L, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, et al. Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX). AO [Internet]. 2014 Feb. 1 [cited 2024 Nov. 24];53(2):186-94. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26983